Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: ZHENG, Zu-Guo (China Pharmaceutical University, State Key Laboratory of Natural Medicines, Nanjing, China)
  • Co-author(s): Zu-Guo Zheng: State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China
    Hui-Jun Li: State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China
    Xiaojun Xu: State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China
  • Abstract:

    Backgrounds

    SREBPs play important roles in the regulation of lipid metabolism, and it is closely related to the occurrence, development of many metabolic diseases. Small molecular inhibitors of SERBPs are important tools in developing efficient treatment to metabolic diseases. However, there is no listing drug targeting SREBPs. Therefore, there is..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses